Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
MasTec
MTZ
$23B
| $6.69M | 0.01% |
+129,900
| New | +$6.42M |
|
1652
RCI Hospitality Holdings
RICK
$230M
| $6.69M | 0.01% |
382,200
-245,400
| -39% | -$4.96M |
|
1653
AstroNova
ALOT
$227M
| $6.64M | 0.01% |
257,176
+35,926
| +16% | +$913K |
|
|
TA
1654
DELISTED
TravelCenters of America LLC
TA
| $6.64M | 0.01% |
366,800
-6,708
| -2% | -$129K |
|
1655
Northrim BanCorp
NRIM
$601M
| $6.64M | 0.01% |
744,400
+76,400
| +11% | +$661K |
|
1656
Zebra Technologies
ZBRA
$18B
| $6.63M | 0.01% |
31,642
-382,089
| -92% | -$77M |
|
1657
Hope Bancorp
HOPE
$1.85B
| $6.62M | 0.01% |
480,564
-70,400
| -13% | -$960K |
|
|
PCMI
1658
DELISTED
PCM, Inc
PCMI
| $6.61M | 0.01% |
188,500
+26,500
| +16% | +$782K |
|
1659
Civista Bancshares
CIVB
$595M
| $6.6M | 0.01% |
293,791
+10,600
| +4% | +$233K |
|
|
PCTI
1660
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $6.59M | 0.01% |
1,487,633
+61,363
| +4% | +$303K |
|
1661
G. Willi-Food International
WILC
$396M
| $6.58M | 0.01% |
664,512
+3,550
| +0.5% | +$32.4K |
|
1662
The Bancorp
TBBK
$2.82B
| $6.57M | 0.01% |
736,000
+20,900
| +3% | +$192K |
|
|
LL
1663
DELISTED
LL Flooring Holdings, Inc.
LL
| $6.56M | 0.01% |
567,800
-299,000
| -34% | -$3.37M |
|
1664
Royal Gold
RGLD
$19.1B
| $6.55M | 0.01% |
+63,900
| New | +$5.76M |
|
|
FG
1665
DELISTED
FGL Holdings Ordinary Shares
FG
| $6.54M | 0.01% |
778,400
+574,438
| +282% | +$4.81M |
|
|
AMNB
1666
DELISTED
American National Bankshares Inc
AMNB
| $6.53M | 0.01% |
168,440
+4,840
| +3% | +$174K |
|
1667
Comfort Systems
FIX
$60.8B
| $6.5M | 0.01% |
127,480
-283,400
| -69% | -$14.6M |
|
|
TSC
1668
DELISTED
TriState Capital Holdings, Inc.
TSC
| $6.5M | 0.01% |
304,500
-65,600
| -18% | -$1.44M |
|
|
LGF.A
1669
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $6.47M | 0.01% |
528,500
+133,500
| +34% | +$1.92M |
|
|
GFN
1670
DELISTED
General Finance Corporation
GFN
| $6.47M | 0.01% |
773,340
-16,600
| -2% | -$144K |
|
1671
China Yuchai International
CYD
$1.71B
| $6.45M | 0.01% |
430,214
+60,500
| +16% | +$934K |
|
1672
National CineMedia
NCMI
$252M
| $6.43M | 0.01% |
98,083
-7,601
| -7% | -$535K |
|
|
IVC
1673
DELISTED
Invacare Corporation
IVC
| $6.43M | 0.01% |
1,239,500
+572,800
| +86% | +$3.73M |
|
1674
Mistras Group
MG
$584M
| $6.43M | 0.01% |
447,240
-25,300
| -5% | -$348K |
|
|
LION
1675
DELISTED
Fidelity Southern Corporation
LION
| $6.42M | 0.01% |
207,300
-54,650
| -21% | -$1.59M |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.